PCVX icon

Vaxcyte
PCVX

Overview Fund Activity

325 hedge funds and large institutions have $15.5B invested in Vaxcyte in 2024 Q3 according to their latest regulatory filings, with 83 funds opening new positions, 130 increasing their positions, 86 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
325
Holders Change
+61
Holders Change %
+23.11%
% of All Funds
4.7%
Holding in Top 10
23
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+53.33%
% of All Funds
0.33%
New
83
Increased
130
Reduced
86
Closed
21
Calls
$90.6M
Puts
$61.4M
Net Calls
+$29.2M
Net Calls Change
+$17.9M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$1.25B
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.31B
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$510M
4
Deutsche Bank
4
Deutsche Bank
Germany
$131M
5
PCH
5
Polar Capital Holdings
United Kingdom
$114M

Top Sellers

1
B
1
Braidwell
Connecticut
$34M
2
O
2
OrbiMed
New York
$44.2M
3
CC
3
Commodore Capital
New York
$105M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$1.81B
5
EAM
5
Eventide Asset Management
Massachusetts
$43.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
WP
26
Woodline Partners
California
$126M +$45.4M +397,042 +56%
KCM
27
Kynam Capital Management
New Jersey
$119M +$32.7M +286,048 +38%
Northern Trust
28
Northern Trust
Illinois
$118M +$11M +96,691 +10%
CAM
29
Cormorant Asset Management
Massachusetts
$114M -$11.4M -100,000 -9%
PCH
30
Polar Capital Holdings
United Kingdom
$114M +$114M +995,779 New
MC
31
Maverick Capital
Texas
$112M +$32.9M +288,341 +42%
Goldman Sachs
32
Goldman Sachs
New York
$108M +$24.3M +212,512 +29%
CC
33
Commodore Capital
New York
$105M -$44M -385,000 -30%
FLSM
34
Frazier Life Sciences Management
California
$100M -$18.3M -160,000 -15%
Pictet Asset Management
35
Pictet Asset Management
Switzerland
$89.2M +$28.3M +248,001 +47%
NHAS
36
Novo Holdings A/S
Denmark
$85.7M -$22.9M -200,000 -21%
Morgan Stanley
37
Morgan Stanley
New York
$79.4M +$32.6M +285,177 +70%
PBPIA
38
Pivotal bioVenture Partners Investment Advisor
California
$73.1M -$17.5M -153,497 -19%
PBA
39
Paradigm Biocapital Advisors
New York
$71.7M +$60.6K +530 +0.1%
Bank of America
40
Bank of America
North Carolina
$65.1M +$11.3M +98,609 +21%
Ensign Peak Advisors
41
Ensign Peak Advisors
Utah
$62.5M +$9.62M +84,153 +18%
American Century Companies
42
American Century Companies
Missouri
$60.4M +$161K +1,411 +0.3%
Federated Hermes
43
Federated Hermes
Pennsylvania
$57.3M +$8.62M +75,410 +18%
Nuveen Asset Management
44
Nuveen Asset Management
Illinois
$53M +$15.9M +138,776 +43%
Brown Advisory
45
Brown Advisory
Maryland
$50.7M +$8.78M +76,822 +21%
Amundi
46
Amundi
France
$48.6M -$840K -7,516 -2%
D.E. Shaw & Co
47
D.E. Shaw & Co
New York
$48.4M +$22.1M +193,291 +84%
Bank of New York Mellon
48
Bank of New York Mellon
New York
$47.1M -$6.46M -56,529 -12%
UBS AM
49
UBS AM
Illinois
$46.7M +$12.9M +112,512 +38%
O
50
OrbiMed
New York
$44.2M -$46.7M -408,900 -51%
1
2
3 4 5